Bedaquilinepretomanidmoxifloxacinpyrazinamide for drugsensitive and drugresistant pulmonary tuberculosis treatment a phase 2c openlabel multicentre partially randomised controlled trial

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By